Navigation Links
PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
Date:6/10/2009

PRINCETON, N.J., June 10 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced its participation at several international professional meetings during the month of June.

    June 23   45th Drug Information Association (DIA) Annual Meeting
              San Diego, California, Booth 321
              Betty Kuhnert, PhD, MBA, Executive Director, Training Services,
              will chair a session entitled Critical Success Strategies for
              Professional Development and will present "So You Have a New
              Job, Now What? Tactics for Surviving a Job Transition."

    June 24   Phacilitate's Active Immunotherapeutics Forum
              Barcelona, Spain
              Joyce Frey-Vasconcells, PhD, Executive Director, PharmaNet
              Consulting, will make a presentation on "Delivering Strategic
              Solutions to Manufacturing and Product Characterization
              Challenges with Allogeneic Therapies."

              AAPS National Biotechnology Conference
              Seattle, Washington, Booth 305
              Taylor Technology's Robert Dodge, PhD, Laboratory Director,
              Immunochemistry and Cell Biology, Jason Morse, Director,
              Information Technology and Lisa Werdal, Database Systems
              Manager, will be presenting their poster: "Development and
              Implementation of an Information Management System for Tiered
              Immunogenicity Sample Testing and Reporting."

              Robert Dodge, PhD, Marisa Castellana, Research Scientist and
              Dania Yaskanin, Associate Director, Immunochemistry, will also
              present their poster entitled "Optimization of Commercial ELISA
              Kits for the Quantitation of Human Luteinizing Hormone and
              Follicle Stimulating Hormone."

    June 30   4th Annual Biopharm Asia Conference
              Singapore
              Duu-Gong Wu, PhD, Executive Director, PharmaNet Consulting, will
              make a presentation entitled "Overview of Follow-on Biologics
              Regulatory and Scientific Issues in US." He will also lead a
              post conference workshop on July 1 on the topic of the FDA's
              approval process for biologics and biological products.

              49th Annual Meeting of the Teratology Society
              Rio Grande, Puerto Rico
              Bengt Danielsson, MD, PhD, Vice President, PharmaNet Consulting,
              will present "Exaggerated Pharmacology Versus True Toxicity."
              Dr. Danielsson's presentation is part of the International Life
              Sciences Institute and the Health and Environmental Sciences
              Institute's (ILSI/HESI) symposium on Maternal Toxicity and its
              Impact on Study Design and Data Interpretation.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,400 employees and 40 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.

    Contact: Anne-Marie Hess
    Phone: (609) 951-6842
    E-mail: ahess@pharmanet.com


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
2. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
3. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
4. PharmaNet Development Group Agrees to be Acquired by JLL Partners
5. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
6. Plexus Awarded Development Contract With QIAGEN
7. AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
8. Microbia, Inc. Names Alex Chu as Vice President of Process Development
9. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug
10. Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development
11. Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity ... intelligent tools designed, tuned and optimized exclusively for Okuma CNC machining centers at ... result of a collaboration among several companies with expertise in toolholding, cutting tools, ...
(Date:6/23/2016)... India , June 23, 2016 ... media market research report to its pharmaceuticals section ... profiles, product details and much more. ... spread across 151 pages, profiling 15 companies and ... available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
(Date:6/22/2016)... , June 22, 2016 Research and ... Global Markets" report to their offering. ... billion in 2014 from $29.3 billion in 2013. The market is ... of 13.8% from 2015 to 2020, increasing from $50.6 billion in ... projected product forecasts during the forecast period (2015 to 2020) are ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):